RACC

10.0200.10%
MF

Michael F. MacLean

Independent Director

Mr. Michael F. MacLean, also known as Mike, CPA, is Independent Director of Latus Bio, Inc. from September 1, 2026. He is Independent Director of Camp4 Therapeutics Corporation from April 2026. Mr. MacLean brings extensive leadership experience across the life sciences industry. He most recently served as Chief Financial Officer of Avidity Biosciences, leading the company through its acquisition by Novartis in 2026. He serves as an Independent Director for CAMP4 Therapeutics and is on the Board of Research Alliance Corporation III. Mr. MacLean has previously served as an Independent Director of Verve Therapeutics through its acquisition by Eli Lilly in 2025 and as Chief Financial Officer and Executive Vice President at both Akcea Therapeutics and PureTech Health. Mr. MacLean served as Senior Vice President of Finance and Chief Accounting Officer at Biogen Idec. He is Independent Director of Research Alliance Corporation III since May 19, 2026. Mr. MacLean was a Chief Financial Officer at Avidity Biosciences, Inc. since April 2022 until February 27, 2026 and served as its Chief Business Officer since April 2022 and served as its Chief Financial Officer since May 2020 until February 27, 2026. He had been Director of Verve Therapeutics, Inc. since May 2021 until July 25, 2025. Mr. MacLean served as Chief Financial Officer of Akcea Therapeutics, Inc. since August 31, 2017 until March 2020. Mr. MacLean served as Chief Financial Officer and Executive Vice President of PureTech Health plc since September 14, 2015 until September 7, 2017. Mr. MacLean joined PureTech from Iron Mountain Inc. Mr. MacLean was Chief Financial Officer of Iron Mountain Inc.’s North American business from July 2014 to June 2015 and was Senior Vice President, Worldwide Controller at Iron Mountain from October 2012 to June 2014. He served as Senior Vice President of Finance at Biogen Inc. from October 6, 2006 to November 3, 2010 and served as its Chief Accounting Officer and Controller from December 6, 2006 to November 3, 2010. Mr. MacLean served as the Chief Accounting Officer and Controller of Biogen MA Inc. from December 6, 2006 to November 3, 2010 and served as its Senior Vice President from October 6, 2006 to November 3, 2010. He served as Managing Director of Disputes and Investigations Practice at Huron Consulting Group Inc. since November 2005. From June 2002 to October 2005, Mr. MacLean was a Partner at KPMG and he was a Partner of Arthur Andersen LLP from September 1999 to May 2002. He was an Audit Partner at global public accounting firms including KPMG. Mr. MacLean assisted clients with financial reporting matters, special investigations and forensic accounting assignments at Huron Consulting Group Inc. He joined Huron from KPMG International Limited, where he served as a Partner in the Boston office from September 1999 to May 2002. He is a Certified Public Accountant. Mr. MacLean holds a BS in Accounting from Boston College Carroll School of Management.

Positions